APA (7th ed.) Citation

Ryzhikov, A. B., Ryzhikov, Е. А., Bogryantseva, M. P., Usova, S. V., Danilenko, E. D., Nechaeva, E. A., . . . Maksyutov, R. A. (2021). A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II). Sankt-Peterburg : NIIÈM imeni Pastera.

Chicago Style (17th ed.) Citation

Ryzhikov, A. B., et al. A Single Blind, Placebo-controlled Randomized Study of the Safety, Reactogenicity and Immunogenicity of the “EpiVacCorona” Vaccine for the Prevention of COVID-19, in Volunteers Aged 18–60 Years (phase I–II). Sankt-Peterburg : NIIÈM imeni Pastera, 2021.

MLA (8th ed.) Citation

Ryzhikov, A. B., et al. A Single Blind, Placebo-controlled Randomized Study of the Safety, Reactogenicity and Immunogenicity of the “EpiVacCorona” Vaccine for the Prevention of COVID-19, in Volunteers Aged 18–60 Years (phase I–II). Sankt-Peterburg : NIIÈM imeni Pastera, 2021.